GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 74 filers reported holding GAMIDA CELL LTD in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $49,290 | +173.8% | 25,539 | +121.9% | 0.00% | – |
| Q3 2022 | $18,000 | -57.1% | 11,510 | -51.8% | 0.00% | – |
| Q2 2022 | $42,000 | -67.9% | 23,902 | -28.7% | 0.00% | -100.0% |
| Q3 2021 | $131,000 | -5.8% | 33,523 | +54.5% | 0.00% | 0.0% |
| Q2 2021 | $139,000 | -52.2% | 21,702 | -39.6% | 0.00% | -50.0% |
| Q1 2021 | $291,000 | – | 35,929 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 3,318,207 | $26,844,000 | 2.86% |
| Stonepine Capital Management, LLC | 244,515 | $1,978,000 | 1.07% |
| Healthcare Value Capital, LLC | 50,000 | $405,000 | 0.90% |
| Rock Springs Capital Management LP | 2,100,300 | $16,991,000 | 0.37% |
| Dorsey Wright & Associates | 3,619 | $29,278,000 | 0.34% |
| FIRST MIDWEST BANK TRUST DIVISION | 302,487 | $2,447,000 | 0.34% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 107,000 | $862,000 | 0.23% |
| Guild Investment Management, Inc. | 15,000 | $121,000 | 0.13% |
| PREMIER ASSET MANAGEMENT LLC | 86,464 | $699,000 | 0.12% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 973,575 | $7,876,000 | 0.12% |